Polarian Partners LLC is a New York City based asset management firm that seeks outstanding private equity opportunities for our investor base in the real estate and healthcare sectors.
has over 20 years of experience in the financial industry. Bin was CFO of E-House (China) Holdings, a NYSE-listed real estate firm with over 20,000 employees. Prior to E-House, Bin was CFO of China Real Estate Information Corp., a company that she helped take public on NASDAQ. Bin also has vast experience on the buy-side (part of the investment team of a $3-billion US hedge fund) and sell-side (Lehman Brothers and BMO Capital Markets in New York) of Wall Street. Bin grew up in China, and has a BA in Economics from Wellesley College and an MBA from Columbia Business School.
has more than 25 years of experience in the financial industry. He served as COO for several hedge funds and investment management firms, and has twice grown assets to multi-billion dollar levels. Peter has successfully managed capital restructurings, SEC examinations, office relocations, technology infrastructure deployment and change management initiatives. Peter also served as CFO for Dunkin Donuts UK where he oversaw their real estate portfolio. Peter has a BA in Business from Villanova University – where he serves on the board – and an MBA from Columbia Business School.
is a veteran of the financial and technology industries. Prior to Polarian, he served as Chief Marketing Officer of Feex, a fund analysis company that helps investors optimize their retirement portfolios. Before that, he was based in Shanghai where he served as Head of Greater China for NASDAQ-listed Verint, a $2.5-billion market cap technology firm. Earlier in his career, he served in various sales and marketing capacities to help Comverse (now Mavenir) grow from a fledgling startup to become a multi-billion dollar global leader in enhanced telecom services. He has a BS in Electrical Engineering from Tufts University and an MBA from Columbia Business School.
is a research scientist, professor, and biotech entrepreneur and consultant who has spent most of his career in biomedical research on cardiovascular disease. A major part of Dan’s research career was spent as Professor in the Division of Cardiology at Weill Cornell Medical College, New York, NY, where he directed a group studying the molecular mechanisms of blood pressure control. Dan later founded Cardiagen Life Sciences, a biotech startup developing small molecule drugs directed at hypertension and heart failure. Dan has extensive experience in clinical and research laboratory management, research regulatory compliance, and scientific publishing, having served for 5 years as Executive Editor of the American Journal of Hypertension. Dan has a PhD in Physiology and Molecular Biology from the University of Sydney and an MBA from Columbia.
is a consultant, innovation professor, investor and entrepreneur. Didier founded and invested in more than 40 startups. He is a board director and shareholder of several digital startup companies and has been a coach at Stanford University and Ecole Polytechnique. Prior to that, he served as VP for Lucent/Avaya, COO for Beijaflore Telecom and was President, Orange North America, based in New York. As Global Account VP for Avaya, he was able to develop sales from €3 M to €25 M in less than 3 years. He has also managed sales responsibility for over $200 M serving major international accounts, with a 15% annual growth rate. Didier has an MBA from Columbia, a PhD.in Computer Science from INRIA, and engineering degrees from Ecole Polytechnique and Telecom ParisTech.